Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.55 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3883310 | 0.90 | HSD11B1 (0.59) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3940044 | 0.89 | LMNA (0.57) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3875065 | 0.87 | HPGD (0.69) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3873566 | 0.87 | HSD11B1 (0.63) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3883798 | 0.86 | HSD11B1 (0.65) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3877107 | 0.85 | HPGD (0.60) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3876577 | 0.85 | CYP19A1 (0.67) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3872241 | 0.83 | LMNA (0.58) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3872431 | 0.82 | HSD11B1 (0.62) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 | |
| SCHEMBL3877412 | 0.81 | CYP19A1 (0.62) | CYP19A1ALDH1A1LMNAHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1814846-B1 | 11BETA-HSD1 INHIBITORS | EVOTEC AG (DE) | 2009-04-08 | — | — | EP | disclosed |
| US-20090069323-A1 | 11beta-hsdi inhibitors | EVOTEC AG (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069323-A1 | 11beta-hsdi inhibitors | HSD3B1, HSD3B2, HSD11B1 | CYP19A1 23/4885ALDH1A1 210/4885LMNA 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.